✦ LIBER ✦

Drug repositioning for orphan diseases

✍ Scribed by Sardana, D.; Zhu, C.; Zhang, M.; Gudivada, R. C.; Yang, L.; Jegga, A. G.

Book ID: 118746099
Publisher: Oxford University Press
Year: 2011
Tongue: English
Weight: 131 KB
Volume: 12
Category: Article
ISSN: 1467-5463
DOI: 10.1093/bib/bbr021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Orphan/rare drug discovery through drug

Orphan/rare drug discovery through drug repositioning

✍ Ramaiah Muthyala 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Drug development for “orphan” diseases

✍ Anthony Cerami 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Drug repositioning for Alzheimer's disea

Drug repositioning for Alzheimer's disease

✍ Corbett, Anne; Pickett, James; Burns, Alistair; Corcoran, Jonathan; Dunnett, Ste 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 374 KB

Orphan drugs and orphan diseases

✍ Jaime Campos-Castelló; Gerard Ponsot; François Feillet; M Vidailhet; Irène Maire 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Orphan drugs for tropical diseases

📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Orphan drug legislation: lessons for neg

Orphan drug legislation: lessons for neglected tropical diseases

✍ Stefano Villa; Amelia Compagni; Michael R. Reich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract In the last 20 years, orphan drug legislation (ODL) has been adopted in several countries around the world (USA, Japan, Australia, and the European Union) and has successfully promoted R&D investments to develop new pharmaceutical products for the treatment of rare diseases. Without the